Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Tueo Health Oversubscribes Seed Round to Support Clinical Study and Growth

Tueo Health
Posted on: 25 Jul 17

PR Newswire

SAN FRANCISCO, July 25, 2017

SAN FRANCISCO, July 25, 2017 /PRNewswire/ -- Tueo Health, a digital health start-up company that has developed a unique solution for monitoring and managing pediatric asthma, has closed $1.1 million in seed round funding. The seed financing was led by Launchpad Digital Health, with participation from Plug and Play, and other strategic investors.

"Asthma is a costly chronic disease that affects more than 7 million children in the US alone," said Tueo Founder and CEO, Bronwyn Harris, MD.  "Over half of asthma related direct healthcare costs are from hospital-based care that could be avoided by better asthma control."

"New methods of passive monitoring make real control of debilitating conditions possible, and Tueo Health is leading this effort in conditions of the lungs," said Fred Toney, CEO of Launchpad Digital Health. "With smart inhalers, we can now better measure dosing of drugs, but Tueo provides the critical information necessary on a daily basis to assess how the patient is responding."

Tueo Health has created an integrated solution that combines sensor-based nocturnal monitoring; personalized analytics based on physiologic data; a mobile app that delivers data and provides educational and clinical context; and an asthma coach that assists in self-management. Prompts and guidance are based on guidelines from the National Asthma Education and Prevention Program.

"As a parent of a child with asthma, it makes me sad that so many children are limited by the disease," said Harris, who is both a biomedical engineer and pediatric cardiologist. "We are leveraging technological advancements to create the data and tools families need to manage the condition and improve quality of life."

Tueo will use the financing to conduct a clinical study starting in September and drive continued application development and market positioning.

About Tueo Health

Tueo Health is a San Francisco-based company that is building a digital health solution to empower families to take better control of asthma management. The first Tueo solution is based on passive nocturnal monitoring, a mobile app, and targeted coaching and education. More information can be found at: www.tueohealth.com.

About Launchpad Digital Health

Launchpad Digital Health is the most active seed stage fund for digital health in the U.S.  Its unique side-by-side immersion program includes more capital, more time and more intensity for its portfolio companies and their founders. 

View original content:http://www.prnewswire.com/news-releases/tueo-health-oversubscribes-seed-round-to-support-clinical-study-and-growth-300492617.html

SOURCE Tueo Health

PR Newswire
www.prnewswire.com

Last updated on: 25/07/2017

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.